Leader of the domestic pharmaceutical market – the Farmak Company – took part in the Ukrainian interdepartmental scientific and practical conference "Medical support of the anti-terrorist operation: scientific, organizational, medical, and social aspects." The event was held on June 14-15 at the National Military Medical Clinical Center "Main Military Clinical Hospital" of the Ministry of Defense of Ukraine.
During the conference, the Farmak Company presented a range of drugs that are used and can be used in the combat operational zone.
The conference was attended by V.I.Tsymbaliuk, President of the Academy of Medical Sciences of Ukraine, NAMS academician (chairman) and V.V. Shafransky, Deputy Minister of Health of Ukraine (Dep. Chairman), as well as military doctors of law enforcement agencies (Ministry of Defense, Ministry of Interior, Security Service, Border Guard and others), representatives of the Presidential Administration of Ukraine, Verkhovna Rada, the Cabinet Secretariat, the Office of the National Security and Defense Ukraine, the Prosecutor General, representatives of the NATO Liaison Office in Ukraine and the World Health Organization in Ukraine.
The event discussed the medical support of the anti-terrorist operations in Donetsk and Lugansk regions, existing problems and justified solutions.
Farmak seeks to provide our defenders with access to efficient, high-quality and safe medicines, with a positive benefits / risks ratio.
The pharmaceutical company JSC “Farmak” considers the possibility of launching the manufacture of products, in particular, diagnostic test kits, to combat coronavirus spread. “Now we analyse the possibility of arranging the release of supportive care products, disinfectants and antiseptics, diagnostic test kits, protective medical products, including masks, ...
Farmak reinvests 95% of its profits in the development. “We have never paid more than 5% of our profits as dividends. We have reinvested everything in the development. Due to this, Farmak’s capitalization can be estimated at $850 million to $1 billion today. If I sell the shares that I hold, I will earn a […]
The Memorandum is aimed at developing the mutual cooperation in the implementation of the state programs of the Republic of Uzbekistan for the further development of the national pharmaceutical industry. “We know the Uzbek market well and we are committed to develop cooperation. Farmak has been present in Uzbekistan since 2004. The residents of this [&hellip...